Nektar Therapeutics (NKTR)
1.76
+0.16
(+10.00%)
USD |
NASDAQ |
May 10, 16:00
1.79
+0.03
(+1.70%)
After-Hours: 20:00
Nektar Therapeutics Price: 1.76 for May 10, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| May 09, 2024 | 1.64 | 1.69 | 1.60 | 1.60 | 966120.0 |
| May 08, 2024 | 1.64 | 1.725 | 1.52 | 1.64 | 2.069M |
| May 07, 2024 | 1.64 | 1.67 | 1.48 | 1.50 | 1.755M |
| May 06, 2024 | 1.60 | 1.67 | 1.55 | 1.65 | 912239.0 |
| May 03, 2024 | 1.74 | 1.74 | 1.55 | 1.57 | 1.141M |
| May 02, 2024 | 1.71 | 1.79 | 1.59 | 1.67 | 2.477M |
| May 01, 2024 | 1.45 | 1.65 | 1.445 | 1.65 | 1.731M |
| Apr 30, 2024 | 1.45 | 1.52 | 1.40 | 1.46 | 814438.0 |
| Apr 29, 2024 | 1.35 | 1.53 | 1.35 | 1.46 | 1.607M |
| Apr 26, 2024 | 1.33 | 1.38 | 1.31 | 1.32 | 559095.0 |
| Apr 25, 2024 | 1.36 | 1.37 | 1.29 | 1.32 | 1.054M |
| Apr 24, 2024 | 1.37 | 1.42 | 1.37 | 1.38 | 958333.0 |
| Apr 23, 2024 | 1.39 | 1.43 | 1.31 | 1.42 | 1.101M |
| Apr 22, 2024 | 1.31 | 1.41 | 1.29 | 1.36 | 1.970M |
| Apr 19, 2024 | 1.33 | 1.33 | 1.20 | 1.24 | 4.718M |
| Apr 18, 2024 | 1.32 | 1.36 | 1.27 | 1.32 | 3.576M |
| Apr 17, 2024 | 1.48 | 1.50 | 1.28 | 1.35 | 3.262M |
| Apr 16, 2024 | 1.47 | 1.575 | 1.45 | 1.49 | 1.593M |
| Apr 15, 2024 | 1.68 | 1.70 | 1.50 | 1.57 | 2.847M |
| Apr 12, 2024 | 1.58 | 1.675 | 1.48 | 1.67 | 4.832M |
| Apr 11, 2024 | 1.40 | 1.75 | 1.36 | 1.58 | 13.19M |
| Apr 10, 2024 | 1.21 | 1.39 | 1.16 | 1.29 | 4.904M |
| Apr 09, 2024 | 1.30 | 1.34 | 1.24 | 1.25 | 2.079M |
| Apr 08, 2024 | 1.34 | 1.395 | 1.22 | 1.31 | 3.137M |
| Apr 05, 2024 | 1.32 | 1.47 | 1.26 | 1.32 | 5.026M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
0.4227
Minimum
Nov 28 2023
36.27
Maximum
Jul 03 2019
11.92
Average
14.08
Median
Aug 24 2021
Price Benchmarks
| Stereotaxis Inc | 2.185 |
| Vanda Pharmaceuticals Inc | 5.04 |
| Cara Therapeutics Inc | 0.7122 |
| Avid Bioservices Inc | 8.65 |
| Rigel Pharmaceuticals Inc | 0.9844 |
Price Related Metrics
| PS Ratio | 3.711 |
| Price to Book Value | 2.467 |
| Earnings Yield | -82.95% |
| Market Cap | 323.18M |